Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2016.11.047PMID 27894872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ligand efficiency metrics: why all the fuss?

  2015cited by this paper
• New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid

  2015cited by this paper
• Design, synthesis and in vitro cell-based evaluation of the anti-cancer activities of hispolon analogs.

  2015cited by this paper
• Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells.

  2015cited by this paper
• Totally drug‐resistant tuberculosis and adjunct therapies

  2015cited by this paper
• The anticancer effects of hispolon on lung cancer cells.

  2014cited by this paper
• Natural product and natural product derived drugs in clinical trials.

  2014cited by this paper
• Totally drug-resistant tuberculosis in India.

  2012cited by this paper
• Extensively drug-resistant tuberculosis in India: A review

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Totally drug-resistant TB emerges in India

  2012cited by this paper
• Hispolon Protects against Acute Liver Damage in the Rat by Inhibiting Lipid Peroxidation, Proinflammatory Cytokine, and Oxidative Stress and Downregulating the Expressions of iNOS, COX-2, and MMP-9

  2011cited by this paper
• Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro.

  2010cited by this paper
• Extensively drug-resistant tuberculosis: a new face to an old pathogen.

  2009cited by this paper
• Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase

  2009cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway.

  2008cited by this paper
• Platensimycin: a promising antimicrobial targeting fatty acid synthesis.

  2008cited by this paper
• Antituberculosis drugs and hepatotoxicity.

  2007cited by this paper
• Isolation and structure of platencin: a FabH and FabF dual inhibitor with potent broad-spectrum antibiotic activity.

  2007cited by this paper
• Antituberculosis drugs and hepatotoxicity

  2006cited by this paper
• Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy.

  2006cited by this paper
• American Thoracic Society Documents An Official ATS Statement : Hepatotoxicity of Antituberculosis Therapy

  2006cited by this paper
• Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors.

  2005cited by this paper
• Ligand efficiency: a useful metric for lead selection.

  2004cited by this paper
• Phelligridins C-F: cytotoxic pyrano[4,3-c][2]benzopyran-1,6-dione and furo[3,2-c]pyran-4-one derivatives from the fungus Phellinus igniarius.

  2004cited by this paper
• Crystal Structure of the Mycobacterium tuberculosisβ-Ketoacyl-Acyl Carrier Protein Synthase III*

  2001cited by this paper
• Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III.

  2001cited by this paper
• The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli.

  2000cited by this paper
• Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.

  1998cited by this paper
• Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay

  1998cited by this paper
• HISPOLON, A YELLOW PIGMENT FROM INONOTUS HISPIDUS

  1996cited by this paper
• Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques

  1994cited by this paper
• Antimicrobial activity of cinnamic acid derivatives.

  1987cited by this paper

• FabH (β-Ketoacyl-ACP Synthase III) -- Promising Novel Antibacterial Target and Its Inhibitors

  2026cites this paper
• Synthesis, characterization, and In Silico studies on new series of hydrazide-hydrazones for potential Anti-tubercular agents

  2025cites this paper
• Design and Synthesis of Dimethylaminomethyl-Substituted Curcumin Derivatives: Potent Anti-Inflammatory, Anti-Oxidant, and Radioprotection Activity, Improved Aqueous Solubility Compared with Curcumin

  2024cites this paper
• Initial report on the multiple biological and pharmacological properties of hispolon: Exploring stochastic mechanisms.

  2024cites this paper
• Protective role of hispolon and its derivatives against apoptosis in cortical neurons induced by electromagnetic radiation from 4G mobile phone

  2023cites this paper
• Synthesis, X-ray diffraction and anti-proliferative biological activity of hispolon derivatives and their (η6-p-cymene)(Hispolonato)Ruthenium[II] chloride complexes

  2022cites this paper
• Hispolon alleviates oxidative damage by stimulating the Nrf2 signaling pathway in PC12 cells.

  2022cites this paper
• Tailored Functionalization of Natural Phenols to Improve Biological Activity

  2021cites this paper
• Hispolon inhibits RANKL induced osteoclast differentiation in vitro.

  2021cites this paper
• Synthesis, Characterization and Antioxidant Activity of Some New 3-(3-(Trifluoromethyl)phenyl)acrylic Acid Derived Hydrazide-Hydrazone Scaffolds

  2020cites this paper
• Opportunities and challenges of using five‐membered ring compounds as promising antitubercular agents

  2020cites this paper
• X-ray crystal structures, density functional theory and docking on deacetylase enzyme for antiproliferative activity of hispolon derivatives on HCT116 colon cancer.

  2019cites this paper
• Curcumin and Hispolon as Potential Antibacterial Agents

  2019influential citation
• Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.

  2019cites this paper
• New potential drug leads against MDR-MTB: A short review.

  2019cites this paper
• Toxicity and Antigenotoxic Effect of Hispolon Derivatives: Role of Structure in Modulating Cellular Redox State and Thioredoxin Reductase

  2018cites this paper
• Novel synthetic analogues of Fluoxetine as potent and selective anti-TB agents

  2018cites this paper
• Synthesis of new C-dimethylated chalcones as potent antitubercular agents

  2018influential citation
• Minimization of the Thiolactomycin Biosynthetic Pathway Reveals that the Cytochrome P450 Enzyme TlmF Is Required for Five‐Membered Thiolactone Ring Formation

  2017cites this paper